Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins-4

<p><b>Copyright information:</b></p><p>Taken from "Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins"</p><p>http://www.translational-medicine.com/content/5/1/32</p><p>Journal of Translational Medicine 2007;5():32-32.</p><p>Published online 2 Jul 2007</p><p>PMCID:PMC1939830.</p><p></p> best response of 'PR' was assigned a score of 2, 'SD' was assigned a score of 1, and 'PD' was assigned a score of 0.5, and these assigned scores were also log2-transformed. Red indicates higher values (i.e., positive fold-change or positive response), and green indicates lower values (i.e., reduction from baseline or no response); grey indicates missing values